Hepatitis B Core Antibody Positive Test Workup

Immediate Serologic Testing

The American Association for the Study of Liver Diseases recommends completing the hepatitis B serologic panel, including HBsAg, anti-HBs, and HBV DNA, to determine the patient's infection status 1, 2, 3
HBsAg distinguishes active infection from resolved infection, while anti-HBs identifies immunity from past infection versus ongoing infection 1, 2, 4
IgM anti-HBc differentiates acute infection from chronic or resolved infection 1, 2, 3

Quantitative HBV DNA is essential for determining viral replication level and treatment decisions, with levels ≥2,000 IU/mL in HBeAg-negative or ≥20,000 IU/mL in HBeAg-positive patients indicating active disease requiring treatment consideration 1, 2, 3
HBeAg and anti-HBe determine disease phase, with HBeAg-positive indicating high viral replication and anti-HBe-positive suggesting lower replication 1, 2, 3

The Centers for Disease Control and Prevention recommends testing all HBcAb-positive patients for HIV antibody/antigen, as coinfection accelerates liver disease progression and alters treatment approach 3
Testing for anti-HCV antibody is also necessary, as hepatitis C coinfection significantly worsens prognosis 3
Anti-HDV antibody testing is required if HBsAg is positive, as HDV only infects in the presence of HBV 6, 3

The American Association for the Study of Liver Diseases recommends hepatology referral for HBcAb-positive patients who are candidates for immunosuppressant therapy to rule out occult HBV infection and decide on pre-emptive antiviral therapy 6
HBV DNA testing is necessary even if HBsAg-negative, as occult infection can reactivate with immunosuppression 1, 6

For confirmed chronic HBV infection, the American Association for the Study of Liver Diseases recommends ALT monitoring every 3-6 months, even in patients not on treatment 3
Periodic HBV DNA levels are necessary to detect changes in viral replication status, and repeat HBeAg/anti-HBe testing is recommended if initially HBeAg-positive to detect seroconversion 3
Biannual ultrasound and AFP are necessary for HCC surveillance once baseline imaging is complete 1, 3